Next Green Wave (fka NXGWF)

[Clonemaster]

The markets may be imploding all around us as well as society going completely irrational. People are discovering the power of cannabis in helping curtail anxiety, depression, and a myriad of other ailments. People need cannabis as medicine right now and it's popularity will not falter, it will continue to grow exponentially. Mike is producing world class products and the demand will expand to other states and countries, I guarantee that.
An excerpt from NCBI regarding cannabis and cancer research...this is published by the Federal Government folks, cannabis is serious medicine not to be taken lightly. It is not difficult to see why the pharma industry is trying to desperately discredit cannabis and spread false information when you consider just how powerful it is. Read on.

Cannabinoids used in cancer are best-known for their palliative effects, including reducing nausea and vomiting, alleviating cancer pain, and stimulating appetite [178,179]. It has been argued that cannabinoids can exert anti-tumor effects directly through the inhibition of cell proliferation and induction of apoptosis, or indirectly through the inhibition of angiogenesis, invasion and metastasis [180]. Numerous studies using synthetic/endo-/phyto-cannabinoids and endocannabinoid system regulators in various cancer cell lines support this notion [181]. The antitumor effects of cannabinoids have also been observed in various animal tumor models [180].
Link to the entire report:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877694/

The endocannabinoid system has been recently recognized as an important modulatory system in the function of brain, endocrine, and immune tissues. It appears to play a very important regulatory role in the secretion of hormones related to reproductive functions and response to stress. The important elements of this system are: endocannabinoid receptors (types CB1 and CB2), their endogenous ligands (N-arachidonoylethanolamide, 2-arachidonoyl glycerol), enzymes involved in their synthesis and degradation, as well as cannabinoid antagonists. In humans this system also controls energy homeostasis and mainly influences the function of the food intake centers of the central nervous system and gastrointestinal tract activity. The endocannabinoid system regulates not only the central and peripheral mechanisms of food intake, but also lipids synthesis and turnover in the liver and adipose tissue as well as glucose metabolism in muscle cells. Rimonabant, a new and selective central and peripheral cannabinoid-1 receptor (CB1) blocker, has been shown to reduce body weight and improve cardiovascular risk factor (metabolic syndrome) in obese patients by increasing HDL-cholesterol and adiponectin blood levels as well as decreasing LDL-cholesterol, leptin, and C-reactive protein (a proinflammatory marker) concentrations. It is therefore possible to speculate about a future clinical use of CB1 antagonists, as a means of improving gonadotrophin pulsatility and fertilization capacity as well as the prevention of cardiovasculary disease and type 2 diabetes mellitus. Drugs acting as agonists of CB1 receptors (Dronabinol, Dexanabinol) are currently proposed for evaluation as drugs to treat neurodegenerative disorders (Alzheimer's and Parkinson's diseases), epilepsy, anxiety, and stroke.

https://www.ncbi.nlm.nih.gov/pubmed/17369778